A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants

Inclusion Criteria: * Participants must be ethnically Japanese (both biological parents are ethnically Japanese). * Healthy male and female participants as determined by no clinically significant deviation from normal in medical history, physical examination, 12-lead ECGs, or clinical laboratory determinations. * Body mass index (BMI) between 18 and 30 kg/m2, inclusive, at screening. Exclusion Criteria: * Any significant acute or chronic medical illness. * Any major surgery within 4 weeks prior to study drug administration, or any surgery planned during the course of the study. * Any history of known or suspected congenital or acquired immunodeficiency state or condition that would compromise the participant's immune status (eg, history of splenectomy). Other protocol-defined inclusion/exclusion criteria apply.